Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Caspase Inhibition in Islet Transplantation

This study has been completed.
Sponsor:
Collaborator:
Conatus Pharmaceuticals Inc.
Information provided by (Responsible Party):
James Shapiro, University of Alberta
ClinicalTrials.gov Identifier:
NCT01653899
First received: July 12, 2012
Last updated: July 5, 2016
Last verified: July 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: June 2016
  Primary Completion Date: June 2016 (Final data collection date for primary outcome measure)